Godavari Drugs Share Price
Start SIP in Godavari Drugs
Start SIPGodavari Drugs Performance
Day Range
- Low 0
- High 0
52 Week Range
- Low 0
- High 0
- Open Price0
- Previous Close0
- Volume
Godavari Drugs Investment Rating
-
Master Rating:
-
Godavari Drugs has an operating revenue of Rs. 153.50 Cr. on a trailing 12-month basis. An annual revenue de-growth of -2% needs improvement, Pre-tax margin of 4% needs improvement, ROE of 14% is good. The company has a reasonable debt to equity of 29%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 19% and 33% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 20% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 94 which is a GREAT score indicating consistency in earnings, a RS Rating of 70 which is FAIR indicating the recent price performance, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 63 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 32 | 39 | 43 | 40 | 35 | 37 |
| Operating Expenses Qtr Cr | 29 | 34 | 40 | 36 | 33 | 35 |
| Operating Profit Qtr Cr | 3 | 4 | 4 | 3 | 2 | 3 |
| Depreciation Qtr Cr | 1 | 1 | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 1 | 1 | 1 | 1 | 1 | 1 |
| Tax Qtr Cr | 0 | 0 | 1 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 2 | 3 | 1 | 1 | 1 | 1 |
Godavari Drugs Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 9
- Bearish Moving Average
- ___
- 7
- 20 Day
- ₹130.90
- 50 Day
- ₹119.96
- 100 Day
- ₹111.64
- 200 Day
- ₹104.84
- 20 Day
- ₹134.97
- 50 Day
- ₹115.19
- 100 Day
- ₹106.60
- 200 Day
- ₹102.68
Godavari Drugs Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 140.67 |
| Second Resistance | 151.18 |
| Third Resistance | 158.37 |
| RSI | 52.06 |
| MFI | 30.71 |
| MACD Single Line | 7.69 |
| MACD | 5.56 |
| Support | |
|---|---|
| First Support | 122.97 |
| Second Support | 115.78 |
| Third Supoort | 105.27 |
Godavari Drugs Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 35,363 | 1,936,124 | 54.75 |
| Week | 23,398 | 1,596,666 | 68.24 |
| 1 Month | 71,047 | 4,399,241 | 61.92 |
| 6 Month | 24,987 | 1,741,813 | 69.71 |
Godavari Drugs Result Highlights
Godavari Drugs Synopsis
BSE-Medical-Generic Drugs
Godavari Drugs is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 159.62 Cr. and Equity Capital is Rs. 7.53 Cr. for the Year ended 31/03/2023. Godavari Drugs Ltd. is a Public Limited Listed company incorporated on 02/12/1987 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24230TG1987PLC008016 and registration number is 008016.| Market Cap | 103 |
| Sales | 154 |
| Shares in Float | 0.35 |
| No of funds | 4 |
| Yield |
| Book Value | 2.65 |
| U/D Vol ratio | 2.9 |
| LTDebt / Equity | 29 |
| Alpha | 0.09 |
| Beta | 0.55 |
Godavari Drugs Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 53.16% | 53.16% | 53.16% | 53.16% |
| Financial Institutions/ Banks | 0.5% | 0.5% | 0.5% | 0.5% |
| Individual Investors | 38.96% | 39.1% | 38.88% | 38.99% |
| Others | 7.38% | 7.24% | 7.46% | 7.35% |
Godavari Drugs Management
| Name | Designation |
|---|---|
| Mr. Ghanshyam Jaju | Chairman |
| Mr. Mukund Kakani | Managing Director |
| Mr. Mohit Jaju | WholeTime Director & CFO |
| Mr. Mahendra Bhalerao | Non Exe. & Ind. Director |
| Mr. Dilip Keshavlal Patel | Independent Director |
| Mr. Syed Anis Hussain | Non Exe. & Ind. Director |
| Mr. Ramesh Babu Telugu | Non Exe. & Ind. Director |
| Mrs. Vimala Madon | Non Exe. & Ind. Director |
Godavari Drugs Forecast
Price Estimates
Godavari Drugs Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-14 | Quarterly Results | |
| 2024-05-30 | Quarterly Results | |
| 2024-02-13 | Quarterly Results | (Revised) |
| 2023-11-14 | Quarterly Results | |
| 2023-08-11 | Quarterly Results |
Godavari Drugs FAQs
What is Share Price of Godavari Drugs ?
Godavari Drugs share price is ₹130 As on 20 September, 2024 | 02:32
What is the Market Cap of Godavari Drugs ?
The Market Cap of Godavari Drugs is ₹98 Cr As on 20 September, 2024 | 02:32
What is the P/E ratio of Godavari Drugs ?
The P/E ratio of Godavari Drugs is 15.4 As on 20 September, 2024 | 02:32
What is the PB ratio of Godavari Drugs ?
The PB ratio of Godavari Drugs is 2.5 As on 20 September, 2024 | 02:32